Publication:
Predictive factors for acne flare during isotretinoin treatment

dc.contributor.authorsDemircay, Zeynep; Kus, Sadiye; Sur, Haydar
dc.date.accessioned2022-03-12T17:34:49Z
dc.date.accessioned2026-01-11T08:46:04Z
dc.date.available2022-03-12T17:34:49Z
dc.date.issued2008
dc.description.abstractFlare of acne is common at the beginning of isotretinoin treatment. However, severe flare is rare. Multiple comedones, male gender and young age are reported as promoting factors. However, detailed information is still limited. Our aim was to investigate the incidence, types and course of acne flare and the predictive factors for its occurrence. 244 patients were enrolled. Acne grade was defined according to global acne grading system (GAGS) score. Flare was classified according to the increase in number of inflammatory nodules and treatment requirements of the patients. Risk factors (age, sex, duration of acne, basal acne grade, baseline numbers of comedones, papule-pustules, nodules, hyperandrogenism, and presence of sinuses) were investigated. 161 patients completed the study. 79 patients (32%) had facial and/or truncal flare. Flare was mild in 18% (n = 44), moderate in 10% (n = 24), and severe in 4.5% (n = 11) of the patients. For severe flare, male sex, severe acne, GAGS cut-off score greater than 28, presence of more than 44 facial comedones and 2 facial nodules and presence of truncal nodules were found to be predictive. Recognizing predictive factors for severe flare may help to take early precautions and to prevent severe flares which may result with permanent scars.
dc.identifier.doi10.1684/ejd.2008.0441
dc.identifier.eissn1952-4013
dc.identifier.issn1167-1122
dc.identifier.pubmed18573721
dc.identifier.urihttps://hdl.handle.net/11424/229076
dc.identifier.wosWOS:000257827000017
dc.language.isoeng
dc.publisherJOHN LIBBEY EUROTEXT LTD
dc.relation.ispartofEUROPEAN JOURNAL OF DERMATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectacne
dc.subjectisotretinoin
dc.subjectflare
dc.subjectacne fulminans
dc.subjectdeterioration
dc.subjectpredictive factors
dc.subjectORAL ISOTRETINOIN
dc.subject13-CIS-RETINOIC ACID
dc.subjectFULMINANS
dc.subjectVULGARIS
dc.subjectTHERAPY
dc.subjectANXIETY
dc.titlePredictive factors for acne flare during isotretinoin treatment
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage456
oaire.citation.issue4
oaire.citation.startPage452
oaire.citation.titleEUROPEAN JOURNAL OF DERMATOLOGY
oaire.citation.volume18

Files